Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3806116
Max Phase: Preclinical
Molecular Formula: C30H51N3O
Molecular Weight: 469.76
Molecule Type: Small molecule
Associated Items:
ID: ALA3806116
Max Phase: Preclinical
Molecular Formula: C30H51N3O
Molecular Weight: 469.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N1CCC[C@@H]2[C@@H](C[C@@H]3CC[C@@H]4[C@@H]5C[C@@H]6[C@@H](C[C@@H](C)C[C@@H]6N(C)C5)C[C@@H]4N3)C[C@H](C)C[C@@H]21
Standard InChI: InChI=1S/C30H51N3O/c1-18-11-22-16-28-25(23-15-27(22)29(12-18)32(4)17-23)8-7-24(31-28)14-21-10-19(2)13-30-26(21)6-5-9-33(30)20(3)34/h18-19,21-31H,5-17H2,1-4H3/t18-,19+,21-,22+,23-,24+,25-,26-,27-,28+,29+,30+/m1/s1
Standard InChI Key: VDFRKVDBZHAYRF-HVFGFDBQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 469.76 | Molecular Weight (Monoisotopic): 469.4032 | AlogP: 5.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 35.58 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 11.09 | CX LogP: 4.23 | CX LogD: -0.87 |
Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.61 | Np Likeness Score: 1.83 |
1. Ishiuchi K, Jiang WP, Fujiwara Y, Wu JB, Kitanaka S.. (2016) Serralongamines B-D, three new Lycopodium alkaloids from Lycopodium serratum var. longipetiolatum, and their inhibitory effects on foam cell formation in macrophages., 26 (11): [PMID:27086123] [10.1016/j.bmcl.2016.04.019] |
Source(1):